90-90-90 targets: Reaching the first 90 diagnosing exposed babies using the virologic HIV DNA nucleic acid-based technique
Abstract views: 68 / PDF downloads: 32
DOI:
https://doi.org/10.5152/EurJTher.2017.05058Keywords:
PMTCT, HAART, infant, dried blood spot, polymerase chain reactionAbstract
Objective: The HIV pandemic has continued to be a huge challenge in Nigeria, with the problem of stigmatization reducing the chances of early determination of HIV status in pregnant women, which may increase the chances of transmission to the child from the mother. Our study was designed to determine the trend as well as diagnosis of HIV infection in exposed infants. It will also determine among infants the factors associated with the transmission of the infection from their mothers.
Methods: This was a study of HIV-exposed infants conducted between January 2013 and December 2015. The study population was HIV-exposed infants. Dried blood spots (DBS) were analyzed using the polymerase chain reaction technique.
Results: Only 18.3%, 20.1%, and 14.2% of the babies had their DBS samples taken at six weeks of age in 2013, 2014, and 2015, respectively. The percentage of positives across the three years was 3.6%, 3.2%, and 3.1%, as the majority of the babies took single-dose nevirapine and had exclusive breastfeeding, but only 1.5% and 1.3% of the babies within 18-month PMTCT retested for 2013 and 2014 were confirmed positive after cessation of all exposures.
Conclusion: ART administration to both HIV-infected mothers and their babies has demonstrated an effective mechanism of the PMTCT program, as this is evident in the low positivity outcome. However, the feat of mother-to-baby HIV transmission elimination achieved by Cuba, Armenia, Belarus, and Thailand is achievable in Nigeria through provision of universal access to health care.
Metrics
References
UNAIDS. Report on the Global AIDS Epidemic Geneva: UNAIDS; 2010. Google Scholar.
Charurat M, Datong P, Matawal B, Ajene A, Blattner W, Abimiku A. Timing and determinants of mother-to-child transmission of HIV in Nigeria. Int J Gynaecol Obstet 2009; 106: 8-13.
Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA et al. CHER study Team. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359: 2233-44.
Global Health Observatory (Internet). 2011. Available from: http://apps.who.int/ghodata/
The Petra Study Team. Efficacy of three short course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-I from mother to child in Tanzania, South Africa and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002; 359: 1178-86.
Lallemant M, Jourdian G, Lecoeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S et al. Single dose perinatal Nevirapine plus standard zidovudine for prevention of mother-to-child transmission of HIV-I in Thailand. N Engl J Med 2004; 351: 217-28.
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C et al. Intrepartum and neonatal single-dose Nevirapine compared with Zidovudin for prevention of mother-to-child transmission of HIV-1 Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354: 795-802.
Newell M, Coovadia H, Cortina- Borja M, Rollins N Gaillard P, Dabis F. Mortality of Infected and Uninfected infants born to HIV-infected with HIV type 1. Clin Infect Dis. 2004; 39: 1692-8.
Agboola GB, Usman SO, Yisa OU, Umeozulu FC, Ipinmoye TO. HIV/AIDS, sexual practices, reproductive health and risk assessment among informal sector workers in Ondo State Nigeria. J Environ & Occupat Sci 2015; 4: 158-62.
Usman SO, Agboola GB, Yisa UO, Umeozulu FO, Kalejaye OO. Knowledge about HIV/AIDS, sexual practices, reproductive health and risk assessment among workers in the formal sector of Ondo State, Nigeria. Int J Innov Med Edu Res. 2016; 2: 13-7.
World Health Organisation (WHO). Towards Universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress Report 2010.
Sherman GG. Dried Blood Spots Improve access to HIV diagnosis and care for infants in low- resource settings. J Acq Immun Def Syndr (JAIDS) 2005; 38: 615-7.
Chukwuemeka IK, Fatima CI, Kabiru ZK, Olukayode O. The impact of a prevention of mother to child transmission program in a Nigerian early infant diagnosis centre. Niger Med J 2014; 55: 204-8.
Imade PE, Uwakwe NO, Omeregie R, Eghafona NO. Effect of Prevention of the mother to child transmission program on the prevalence of postnatal HIV infection in Benin, City Nigeria. Fooyin I Health Sci 2010; 2: 58-61.
Buchanan AM, Dow DE,Massambu CG, Nyombi B, Shayo A et al. Progress in the prevention of mother to child transmission of HIV in three regions of Tanzania: A retrospective analysis: PLOS ONE 2014; 9: e88679.
Noubiap JJ, Bangoe A, Agokeng S. Mother-to-child transmission of HIV: findings from an Early Infants Diagnosis program in Bertoua, Eastern Cameroon. The Pan Afr Med J 2013; 15: 2551-7.
Malawi HIV and AIDS monitoring and evaluation report: 2008-2009. UNGASS Country progress report, Geneva Joint United Nations Programme on HIV/AIDS, 2010.
Huang Z, Jin M, Zhou H, Dong Z, Zhang S, Han J et al. The uptake of prevention of mother-to-child HIV Transmission programs in china: A Systematic Review and Meta-Analysis. PLOS ONE 2015; 10: e0135068.
Iregbu KC, Modibbo IF, Medugu N, Abdullahi N, Nwajiobi-Princewill PI, Aigbe AI, et al. Retrospective study of the prevalence of HIV infection among exposed children in National Hospital Abuja. Arch Niger Med Med Sci. 2011; 8: 18-24.
Doherty T, Sanders D, Goga A, Jackson D. Implications of the new WHO Guidelines in HIV and Infant feeding for child survival in South Africa. Bulletin of the World Health Organization [Internet]. 2011; 89: 62-67. Available from: //www.who.int/bulletin/volumes/89/1/10-079798/en/.
Becquet R, Bland R, Leroy V, Rollins NC, Ekouevi DK, Coutsoudis A, et al. Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African Cohorts. PLOS One 2009; 4: e7397.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.